Kirk, A., Guasch, A., Xu, H., Cheeseman, J., Mead, S., Ghali, A., … Pearson, T. (2014). Alemtuzumab, Belatacept and Sirolimus: A Path to Monotherapy Belatacept. In AMERICAN JOURNAL OF TRANSPLANTATION (Vol. 14, pp. 80–80).

Kirk, A., A. Guasch, H. Xu, J. Cheeseman, S. Mead, A. Ghali, A. Mehta, et al. “Alemtuzumab, Belatacept and Sirolimus: A Path to Monotherapy Belatacept.” In AMERICAN JOURNAL OF TRANSPLANTATION, 14:80–80, 2014.

Kirk A, Guasch A, Xu H, Cheeseman J, Mead S, Ghali A, et al. Alemtuzumab, Belatacept and Sirolimus: A Path to Monotherapy Belatacept. In: AMERICAN JOURNAL OF TRANSPLANTATION. 2014. p. 80–80.

Kirk, A., et al. “Alemtuzumab, Belatacept and Sirolimus: A Path to Monotherapy Belatacept.” AMERICAN JOURNAL OF TRANSPLANTATION, vol. 14, 2014, pp. 80–80.

Kirk A, Guasch A, Xu H, Cheeseman J, Mead S, Ghali A, Mehta A, Gebel H, Bray R, Horan J, Kean L, Larsen C, Pearson T. Alemtuzumab, Belatacept and Sirolimus: A Path to Monotherapy Belatacept. AMERICAN JOURNAL OF TRANSPLANTATION. 2014. p. 80–80.